The Importance of Herbal Medicines Consumption in COVID-19 Epidemic
AbstractUp now, there are currently no effective antiviral drugs or vaccines are developed against SARS-CoV2. WHO identifies herbal and traditional medicines for COVID-19, have particular importance and many benefits. Therefore, should be tested for probable side effects, and investigating their efficacy and safety through precise clinical trials is crucial. Regarding the COVID-19 epidemic conditions and the lack of definitive treatment, here we propose the use of herbal medicines, especially anti-inflammatory herbal drugs in the control of mild forms of SARS-CoV2 infection. As attempts are underway to discover a treatment for COVID-19, the use of herbal medicine products to prevent and treatment of COVID-19 must be insistently investigated. We searched several electronic databases for finding the reasons for the use of herbal medicines, especially anti-inflammatory herbal drugs during the COVID-19 Epidemic.In this article, using references, we have mention 8 reasons for using herbal medicines during the coronavirus epidemic. Regarding to the high cost and unavailability of some common COVID-19 drugs, the use of herbal remedies can be very beneficial for the treatment of mild cases. Nevertheless, the potential interests of herbal remedies could due to their high confidence in patients, efficacy, safety, and low costs.
Zhou P, Lou YX, Wang XG, Hu B, Zhang L, Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020; 579 (7798): 270–3.
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924.
Li L, Li R, Wu Z, Yang X, Zhao M, Liu J, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care. 2020;10:1–9.
https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine?gclid=EAIaIQobChMI35Dkybj86wIVSubtCh0EWwNUEAAYASAAEgJhs_D_BwE/04 May 2020
https://www.who.int/news-room/detail/31-08-2020-in-who-global-pulse-survey-90-of-countries-report-disruptions-to-essential-health-services-since-covid-19-pandemic/31 August 2020
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020; 80(4):401-406.
Albano D, Bertagna F, Bertoli M, Bosio G, Lucchini S, Motta F, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61(5):632–6.
Lai C-C, Wang C-Y, Hsueh P-R. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020; 53(4):505-512.
Panyod S, Ho C-T, Sheen L-Y. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective. J Tradit Complement Med. 2020; 10(4): 420–427.
Ernst E. Herbal medicines put into context. British Medical Journal Publishing Group; 2003; 327(7420): 881–882.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.